| MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics R Gil-Redondo, R Conde, C Bruzzone, ML Seco, M Bizkarguenaga, ... Cardiovascular Diabetology 23 (1), 1-13, 2024 | 1 | 2024 |
| Stratified analyses refine association between TLR7 rare variants and severe COVID-19 J Boos, CI van der Made, G Ramakrishnan, E Coughlan, R Asselta, ... Human Genetics and Genomics Advances, 2024 | | 2024 |
| Link between persistent, unexplained gammaGT elevation and Porto-Sinusoidal Vascular Disorder N Pugliese, FR Ponziani, F Cerini, L di Tommaso, F Turati, M Maggioni, ... JHEP Reports, 101150, 2024 | | 2024 |
| Estrogen receptor alpha in the female liver: Dr. Jekyll and Mr. Hyde S Della Torre, A Cherubini, L Valenti Journal of hepatology, S0168-8278 (24) 00330-1, 2024 | | 2024 |
| Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease A Cherubini, S Della Torre, S Pelusi, L Valenti Trends in Molecular Medicine, 2024 | | 2024 |
| A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease H Zhang, G Targher, CD Byrne, SU Kim, VWS Wong, L Valenti, ... Hepatology International, 1-24, 2024 | | 2024 |
| Hepatic Estrogen Receptor alpha drives masculinization in post-menopausal women with MASLD C Meda, V Benedusi, A Cherubini, L Valenti, A Maggi, S Della Torre JHEP Reports, 101143, 2024 | | 2024 |
| EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) F Tacke, P Horn, VWS Wong, V Ratziu, E Bugianesi, S Francque, ... Journal of Hepatology, 2024 | 4 | 2024 |
| Evaluation of Google Search Trends for Liver Diseases in Europe. A Teufel, T Itzel, A Zimmermann, D Dumitrascu, E Bugianesi, L Valenti, ... Journal of Gastrointestinal & Liver Diseases 33 (2), 2024 | | 2024 |
| Multi‐omics analysis reveals a crosstalk between ferroptosis and peroxisomes on steatotic graft failure after liver transplantation Z Liu, H Zhu, J Zhao, L Yu, S Que, J Xu, L Geng, L Zhou, L Valenti, ... MedComm 5 (6), e588, 2024 | | 2024 |
| THU-218 A novel role for the epigenetic regulator SUV420H1 in MASLD and its complications A Pagani, LB Volpe, M Pettinato, F Malvestiti, V Furiosi, R Carleo, A Nai, ... Journal of Hepatology 80, S571, 2024 | | 2024 |
| TOP-144-YI Heterozygosity for rare Apolipoprotein B variants predispose to severe metabolic associated steatotic liver disease M Mureddu, S Pelusi, L Ronzoni, F Malvestiti, V Moretti, H Eigadeh, ... Journal of Hepatology 80, S704-S705, 2024 | | 2024 |
| THU-286 PNPLA3 p. I148M variant affects lipid droplets number and size in patient-derived liver organoids E Casirati, A Cherubini, L Cerami, F Carli, A Gastaldelli, D Prati, ... Journal of Hepatology 80, S593, 2024 | | 2024 |
| WED-130 Prevalence and predictors of porto-sinusoidal vascular disorder in patients with persistent and unexplained gamma-glutamyl transferase elevation: a multicenter study N Pugliese, FR Ponziani, F Cerini, L Di Tommaso, F Turati, M Maggioni, ... Journal of Hepatology 80, S705-S706, 2024 | | 2024 |
| TOP-301 Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in steatotic liver disease S Pelusi, A Marchetti, F Malvestiti, A Ricchiuti, L Ronzoni, M Lionetti, ... Journal of Hepatology 80, S459, 2024 | | 2024 |
| FRI-290 Evaluation of ChatGPT as a counselling tool for Italian-speaking MASLD patients: assessment of accuracy, completeness and comprehensiveness N Pugliese, D Polverini, R Lombardi, G Pennisi, F Ravaioli, A Armandi, ... Journal of Hepatology 80, S496, 2024 | | 2024 |
| WED-293 Effectiveness of on different models of care based on Fibrosis-4 and/or liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk … GP Caviglia, A Ferro, A Armandi, R D'Ambrosio, P Lampertico, G Periti, ... Journal of Hepatology 80, S544, 2024 | | 2024 |
| FRI-275-YI Liver fibrosis and Lipoprotein (a) levels in individuals with metabolic dysfunction S Margarita, C Macchi, S Pelusi, C Bianco, G Periti, J Rondena, ... Journal of Hepatology 80, S491-S492, 2024 | | 2024 |
| Poor accuracy and sustainability of the first‐step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population A De Vincentis, F Tavaglione, S Namba, M Kanai, Y Okada, Y Kamatani, ... Alimentary Pharmacology & Therapeutics 59 (11), 1402-1412, 2024 | | 2024 |
| Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models E Caon, M Martins, H Hodgetts, L Blanken, MG Vilia, A Levi, ... Journal of Hepatology 80 (6), 941-956, 2024 | 3 | 2024 |
Anna Ludovica FRACANZANIDepartment of Pathophysiology and Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore在 unimi.it 的电子邮件经过验证
